ATXN2 and Parkinson disease: Initially, researchers observed that the length of poly(Q) repeat amplification in ATXN2 is implicated in the pathogenesis of ALS, SCA2, and Parkinson's disease, and that the sequence encoding the poly(Q) repeat varies across these diseases [76].